Ann Pediatr Endocrinol Metab.
2023 Dec;28(Suppl 1):S23-S24. 10.6065/apem.2244068.034.
Using low-dose octreotide with diazoxide-resistant congenital hyperinsulinism resulting from compound heterozygous mutations in the ABCC8 gene
- Affiliations
-
- 1Department of Pediatrics, Ajou University Hospital, Ajou University School of Medicine, Suwon, Korea
- KMID: 2549335
- DOI: http://doi.org/10.6065/apem.2244068.034
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- A novel mutation of ABCC8 gene in a patient with diazoxide-unresponsive congenital hyperinsulinism
- Congenital hyperinsulinism: current status and future perspectives
- Congenital hyperinsulinism: 2 case reports with different rare variants in ABCC8
- Pasireotide treatment for severe congenital hyperinsulinism due to a homozygous ABCC8 mutation
- A Case of 2-Month-Old Infant with Persistent Hyperinsulinemic Hypoglycemia Presenting as Atonic Seizure
